Combinatorial 3D printed dosage forms for a two-step and controlled drug release.


Journal

European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences
ISSN: 1879-0720
Titre abrégé: Eur J Pharm Sci
Pays: Netherlands
ID NLM: 9317982

Informations de publication

Date de publication:
01 Aug 2023
Historique:
received: 01 02 2023
revised: 15 05 2023
accepted: 02 06 2023
medline: 21 6 2023
pubmed: 6 6 2023
entrez: 5 6 2023
Statut: ppublish

Résumé

Fused deposition modeling (FDM) and selective laser sintering (SLS) are two of the most employed additive manufacturing (AM) techniques within the pharmaceutical research field. Despite the numerous advantages of different AM methods, their respective drawbacks have yet to be fully addressed, and therefore combinatorial systems are starting to emerge. In the present study, hybrid systems comprising SLS inserts and a two-compartment FDM shell are developed to achieve controlled release of the model drug theophylline. Via the use of SLS a partial amorphization of the drug is demonstrated, which can be advantageous in the case of poorly soluble drugs, and it is shown that sintering parameters can regulate the dosage and release kinetics of the drug from the inserts. Furthermore, via different combinations of inserts within the FDM-printed shell, various drug release patterns, such as a two-step or prolonged release, can be achieved. The study serves as a proof of concept, highlighting the advantages of combining two AM techniques, both to overcome their respective shortcomings and to develop modular and highly tunable drug delivery devices.

Identifiants

pubmed: 37277047
pii: S0928-0987(23)00116-1
doi: 10.1016/j.ejps.2023.106486
pii:
doi:

Substances chimiques

Pharmaceutical Preparations 0
Theophylline C137DTR5RG
Dosage Forms 0
Tablets 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

106486

Informations de copyright

Copyright © 2023. Published by Elsevier B.V.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Maria Stromme reports financial support was provided by Swedish Research Council. Maria Stromme reports financial support was provided by Sweden's Innovation Agency.

Auteurs

Christos S Katsiotis (CS)

Division of Nanotechnology and Functional Materials, Department of Materials Science and Engineering, Uppsala University, Box 35, Uppsala SE-751 03, Sweden.

Evgenii Tikhomirov (E)

Division of Nanotechnology and Functional Materials, Department of Materials Science and Engineering, Uppsala University, Box 35, Uppsala SE-751 03, Sweden.

Maria Strømme (M)

Division of Nanotechnology and Functional Materials, Department of Materials Science and Engineering, Uppsala University, Box 35, Uppsala SE-751 03, Sweden.

Jonas Lindh (J)

Division of Nanotechnology and Functional Materials, Department of Materials Science and Engineering, Uppsala University, Box 35, Uppsala SE-751 03, Sweden. Electronic address: jonas.lindh@angstrom.uu.se.

Ken Welch (K)

Division of Nanotechnology and Functional Materials, Department of Materials Science and Engineering, Uppsala University, Box 35, Uppsala SE-751 03, Sweden. Electronic address: ken.welch@angstrom.uu.se.

Articles similaires

Humans Pharmaceutical Preparations Drug Utilization Prescription Drugs
Vancomycin Polyesters Anti-Bacterial Agents Models, Theoretical Drug Liberation

Folate-engineered chitosan nanoparticles: next-generation anticancer nanocarriers.

Prashant Kesharwani, Kratika Halwai, Saurav Kumar Jha et al.
1.00
Chitosan Humans Folic Acid Nanoparticles Drug Carriers

Characterization of 3D printed composite for final dental restorations.

Lucas Eigi Borges Tanaka, Camila da Silva Rodrigues, Manassés Tércio Vieira Grangeiro et al.
1.00
Composite Resins Materials Testing Printing, Three-Dimensional Surface Properties Flexural Strength

Classifications MeSH